Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases
Pooled analysis of three phase 1 and 2 clinical trials published online ahead of print…
Browsing: non-small cell lung cancers
ASCO 2019: Combination checkpoint blockade effective in pre-surgical setting for early-stage lung cancers
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response…